Yahoo
OTC Markets OTCQX - Delayed Quote USD

Reckitt Benckiser Group plc (RBGPF)

72.24 +3.74 (+5.46%)
At close: September 1 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for RBGPF
  • Previous Close 68.50
  • Open 70.69
  • Bid 70.55 x 30000
  • Ask 73.53 x 30000
  • Day's Range 70.69 - 70.69
  • 52 Week Range 58.67 - 90.71
  • Volume 400
  • Avg. Volume 1,109
  • Market Cap (intraday) 45.851B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 12.02
  • EPS (TTM) 6.01
  • Earnings Date --
  • Forward Dividend & Yield 2.91 (4.24%)
  • Ex-Dividend Date Aug 6, 2026
  • 1y Target Est --

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

www.reckitt.com

36,200

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

RBGPF
10.87%
FTSE 100 (^FTSE)
8.64%

1-Year Return

RBGPF
6.12%
FTSE 100 (^FTSE)
17.32%

3-Year Return

RBGPF
9.78%
FTSE 100 (^FTSE)
44.54%

5-Year Return

RBGPF
11.46%
FTSE 100 (^FTSE)
50.90%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 3.17B
Earnings --
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
0.0%

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    44.10B

  • Enterprise Value

    56.67B

  • Trailing P/E

    11.41

  • Forward P/E

    16.05

  • PEG Ratio (5yr expected)

    2.40

  • Price/Sales (ttm)

    2.41

  • Price/Book (mrq)

    5.66

  • Enterprise Value/Revenue

    3.07

  • Enterprise Value/EBITDA

    9.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.09%

  • Return on Assets (ttm)

    7.88%

  • Return on Equity (ttm)

    48.02%

  • Revenue (ttm)

    13.64B

  • Net Income Avi to Common (ttm)

    2.89B

  • Diluted EPS (ttm)

    6.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    878M

  • Total Debt/Equity (mrq)

    179.74%

  • Levered Free Cash Flow (ttm)

    3.09B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: